Characterization of CK1δ-mediated phosphorylation of tau and development of novel pharmacological approaches targeting CK1δ in Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Ulm, Universität Ulm, Dissertation, 2023
- Keyword
-
Signaltransduktion
Phosphorylierung
Proteinkinasen
Proteine
Proteinkinase CK1
Alzheimerkrankheit
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2023
- Creator
-
Roth, Aileen
- DOI
-
10.18725/OPARU-50254
- URN
-
urn:nbn:de:bsz:289-oparu-50330-9
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:54 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roth, Aileen
- Universität Ulm
Time of origin
- 2023
Other Objects (12)
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Pathological relevance of phosphorylation in the loop region of Presenilin 1 in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Pharmacological modulation of mitochondrial dysfunction by Dimebon and Olesoxim in cellular and murine models of Alzheimer`s disease
A network pharmacological approach to investigate the pharmacological effects of CZ2HF decoction on Alzheimer's disease
Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils
Bayesian physics-based modeling of tau propagation in Alzheimer's disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
Cytoskeleton dysfunction as pathomechanism of Alzheimer disease : amyloid-β oligomer toxicity is mediated via Tau missorting, MARK-type phosphorylation of Tau and microtubule breakdown by spastin = Dysfunktion des Zytoskeletts als Pathomechanismus der Alzheimer-Demenz
Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Pathological relevance of phosphorylation in the loop region of Presenilin 1 in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Pharmacological modulation of mitochondrial dysfunction by Dimebon and Olesoxim in cellular and murine models of Alzheimer`s disease
A network pharmacological approach to investigate the pharmacological effects of CZ2HF decoction on Alzheimer's disease
Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils
Bayesian physics-based modeling of tau propagation in Alzheimer's disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
Cytoskeleton dysfunction as pathomechanism of Alzheimer disease : amyloid-β oligomer toxicity is mediated via Tau missorting, MARK-type phosphorylation of Tau and microtubule breakdown by spastin = Dysfunktion des Zytoskeletts als Pathomechanismus der Alzheimer-Demenz
Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Pathological relevance of phosphorylation in the loop region of Presenilin 1 in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Pharmacological modulation of mitochondrial dysfunction by Dimebon and Olesoxim in cellular and murine models of Alzheimer`s disease
A network pharmacological approach to investigate the pharmacological effects of CZ2HF decoction on Alzheimer's disease
Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils
Bayesian physics-based modeling of tau propagation in Alzheimer's disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
Cytoskeleton dysfunction as pathomechanism of Alzheimer disease : amyloid-β oligomer toxicity is mediated via Tau missorting, MARK-type phosphorylation of Tau and microtubule breakdown by spastin = Dysfunktion des Zytoskeletts als Pathomechanismus der Alzheimer-Demenz